116 related articles for article (PubMed ID: 9377851)
1. [Authors' experience with transvaginal administration of progestagens].
Cataldi U; Tridente V; Pazienza S; Brizzi C; Serrao L; Proia L; Quattrini MJ
Clin Ter; 1997 Apr; 148(4):165-72. PubMed ID: 9377851
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
Cicinelli E
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
[TBL] [Abstract][Full Text] [Related]
3. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
Gompel A
Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
[TBL] [Abstract][Full Text] [Related]
4. Routes of delivery for progesterone and progestins.
Sitruk-Ware R
Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
[TBL] [Abstract][Full Text] [Related]
5. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
7. Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study.
Ferrero S; Gerbaldo D; Fulcheri E; Cristoforoni P
Minerva Ginecol; 2002 Dec; 54(6):519-30. PubMed ID: 12432337
[TBL] [Abstract][Full Text] [Related]
8. Uses of progesterone in clinical practice.
Warren MP; Shantha S
Int J Fertil Womens Med; 1999; 44(2):96-103. PubMed ID: 10338267
[TBL] [Abstract][Full Text] [Related]
9. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
10. The impact of micronized progesterone on the endometrium: a systematic review.
Stute P; Neulen J; Wildt L
Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pedersen AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of combined oral hormone replacement therapy in postmenopausal symptoms].
Szántó F; Hörömpöli C
Orv Hetil; 1996 May; 137(20):1079-81. PubMed ID: 8657419
[TBL] [Abstract][Full Text] [Related]
13. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
Sitruk-Ware R
Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
[TBL] [Abstract][Full Text] [Related]
14. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
[TBL] [Abstract][Full Text] [Related]
15. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
16. Parenteral administration of progestins for hormonal replacement therapy.
Nath A; Sitruk-Ware R
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
[TBL] [Abstract][Full Text] [Related]
17. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
18. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]